Begin main content

Reports

We found 5097 result(s)

Virtual colonoscopy (computed tomography colonography)

Published on: October 23, 2002
Result type: Reports
Product Line: Preassessments

Tags

Virtual Colonoscopy, CT Colonography, Colonic Neoplasms, Colonic Polyps, Occult Blood, Sigmoidoscopy, Sigmoidoscopes, Endoscopy, Enema, Barium Sulfate, Colorectal Cancer, Endoscopy, Gastrointestinal, Colonography, Computed Tomographic, Imaging, Colonography, Computed Tomographic, Virtual colonosocopy, Tumeur Colon, ct conolonography, Polype Colon, computer tomography colonography, Sang Occulte, CTC, fecal occult blood testing, Rectosigmoidoscopies, barium enema, Sigmoidoscope, Gastrointestinal, Endoscopie, Lavement, Sulfate Baryum

Hand-carried ultrasound units for point-of-care cardiac examinations

Published on: October 17, 2002
Result type: Reports

Several hand-carried ultrasound units have been developed for point-of-care cardiac examination. Limited small comparative studies indicate that these devices are more accurate than physical examination. Though their diagnostic performance is generally inferior to standard echocardiography, there appears to be close agreement for some conditi...

Tags

Echocardiography, Heart Diseases, Cardiac Diseases, Costs and Cost Analysis, Technology Assessment, Equipment and Supplies, Device Approval, Ultrasound, Interventional, Medical devices, Heart attack, Point of care, OptiGo, SonoHeart Elite, Terason 2000, Échocardiographie, Hand-held echocardiography, Point-of-care echocardiography, Portable echocardiography, Ultrasound stethoscopes, Hand-held ultrasounds, Hand-held ultrasonography, Point-of-care ultrasounds, Point-of-care ultrasonography, Portable ultrasounds, Portable ultrasonography, Cardiopathies, Coût et analyse coût, Biomedical, Évaluation technologie biomédicale, Health technology assessment, HTA, Équipement et appareillage, Medical equipment, Autorisation mise sur marché matériel, Regulatory status, OptiGo, Échocardiographie portative, Échocardiographie au point de service, Stéthoscopes ultrasons, Ultrasons portatifs, Échographie portative, Ultrasons au point de service, Échographie au point de service, Maladies cardiaques, Évaluation des technologies de la santé ETS, Équipement médical, Dispositifs médicaux, Stade de la réglementation

Drug eluting stents: Managing coronary artery stenosis following PTCA

Published on: October 16, 2002
Result type: Reports

Drug eluting stents (DES) release drugs that inhibit tissue growth in narrowed coronary arteries in an effort to prevent restenosis, a renarrowing of the artery. Several types of DES are under investigation in clinical trials; however, none are currently approved for use in Canada. Preliminary trial data are encouraging, demonstrating greater...

Tags

Stents, Coronary Disease, Coronary Artery Stenosis, Coronary Stenosis, Coronary Stenoses, Stenosis, Coronary Restenosis, Coronary Artery Disease, Coronary artery disease, Medical devices, Stent, Stenting, Vaisseaux Coronaires, Maladies, Coronary Diseases, Coronary Heart Diseases, PTCA, Stenose Coronaire, Artery Stenoses, Coronary, Artery Stenosis, Coronary Artery Stenoses, Stenoses, Coronary Artery, Restenose Coronaire, Restenosis, Restenoses, Coronary Restenoses, Drug-eluting, Drug Eluting, Drug-coated, Drug Coated, Drug-releasing, Drug Releasing, Drug Embedded, Sirolimus-eluting, Sirolimus Eluting, Paclitaxel-eluting, Paclitaxel Eluting, Rapamycin-eluting, Rapamycin Eluting, Tacrolimus-eluting, Tacrolimus Eluting, Actinomycin-eluting, Actinomycin Eluting, Cypher Sirolimus-Eluting Stent, BX Velocity Stent, Paclitaxel-Eluting SupraG, SupraG Stent, Paclitaxel-Eluting V-Flex Plus Coronary Stent System, Paclitaxel-Eluting NIRx Stent, NIRx Stent, ACHIEVE Drug Eluting System, Paclitaxel-Coated V-Flex Plus PTX Coronary Stent System, stent, pose d’un stent maladies coronariennes, coronopathies, sténose de l’artère coronaire, ACTP sténose de l’artère coronaire, sténoses coronaires, sténoses artérielles, coronaires, sténose artérielle, coronaire, sténoses des artères coronaires, sténoses, coronariennes, artère coronaire, sténose, coronarienne, artère coronaire resténose, resténoses, resténoses coronariennes, resténose recouvert de médicament, enrobé de médicament, recouvert de médicament, conçu pour délivrer un médicament, à libération de médicament, enrobé de médicament recouvert de sirolimus, enrobé de sirolimus, recouvert de paclitaxel, enrobé de paclitaxel, recouvert de rapamycine, enrobé de rapamycine, recouvert de tacrolimus, enrobé de tacrolimus, recouvert d’actinomycine, enrobé d’actinomycine stent recouvert de sirolimus Cypher, stent Bx Velocity, SupraG recouvert de paclitaxel, stent SupraG, stent coronaire recouvert de paclitaxel V-Flex Plus, stent NIRx recouvert de paclitaxel, stent NIRx, stent recouvert de medicament ACHIEVE, stent coronarien recouvert de paclitaxel V-Flex Plus PTX

Topical ozone therapy for the treatment of diabetic leg ulcers

Published on: October 10, 2002
Result type: Reports
Product Line: Preassessments

Tags

Ozone, Leg Ulcer, Diabetes Mellitus, Complementary Therapies, Occupational Exposure, Diabète, Diabetes, ozone therapy, Ulcere Jambe, diabetic ulcer, diabetic leg ulcer, Therapies Complementaires et Alternatives, alternative therapy, Exposition Professionnelle, occupational health and safety

Treatment of inoperable advanced non-small-cell lung cancer: regimens with or without taxane

Published on: October 8, 2002
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Target Audience The review will be helpful to oncologists and other health care providers, researchers and health authorities involved in the management of cancer care and/or the development of cancer care guidelines. Technology Name The anticancer drugs paclitaxel (Taxol®) and docetaxel (Taxotere®) belong to the taxane family. Disease/Condition...

Tags

Carcinoma, Lung Neoplasms, Lung Cancer, Pulmonary Cancer, Pulmonary Neoplasms, Taxol, Paclitaxel, Taxanes, Lung cancer, Taxane, Tumeur Poumon, Lung tumor, Taxoid, docetaxel, taxotere, cancer bronchopulmonaire

Heart failure: is there a role for angiotensin ll receptor blockers?

Published on: September 20, 2002
Result type: Reports

Angiotensin II receptor blockers (ARBs) directly inhibit the angiotensin II type 1 receptors, which suppresses the reninangiotensin-aldosterone system (RAAS). Six ARBs are approved in Canada for the treatment of hypertension, none are yet approved for the treatment of heart failure (HF). Evidence comparing ARBs to angiotensin converting enzym...

Tags

Angiotensin, Angiotensin Receptors, Angiotensin-Converting Enzyme Inhibitors, ACE Inhibitors, Angiotensin Converting Enzyme, Angiotensin-Converting Enzyme Antagonists, Enzyme Inhibitors, Heart Failure, Heart, Cardiovascular Diseases, Disease, Losartan, Cozaar, Anti-Arrhythmia Agents, Antihypertensive Agents, Hypertension, Blood Pressure, Stroke, Anhydrides, Anilides, Phenylamines, Aniline Hydroxylase, N,N-bis(2-chloroethyl)aniline, Lymphocin, Local Antiinfective Agents, Lymphocyte Immune Globulin, Anti-Thymocyte Globulin (Equine), Bicarnesine, Altidudinal Hemianopia, Hemicholinium, 5-Iododeoxyuridine, Iododeoxyuridine, Aryepiglottic Muscle, Abnormal Reflex, Abnormal Reflexes, Calcium Oscillations, Calcium Puffs, Heart failure, Cardiovascular, Hypertension, Blood pressure, Stroke, Dental, Receptors, Recepteur Angiotensine, Angiotensin recptor blockers, ARBs, Inhibiteurs Dipeptidyl Carboxypeptidase I, Inhibitors, Antagonists, Angiotensin-Converting Enzyme, ACE, Angiotensin Converting Enzyme Antagonists, Enzyme Antagonists, Angiotensin-Converting, Inhibitors, Congestive, Failure, Appareil cardiovasculaire, maladies, Cardiovascular Disease, Diseases, Losartane, Hypertension Arterielle, High Blood Pressure, High, CV 11974, Candesartan, Candesartan Cilexetil, Atacand, Eprosartan Mesylate, Teveten, Irbesartan, Avapro, Telmisartan, Micardis, Valsartan, Diovan

Scleral support surgery for pathologic myopia

Published on: September 20, 2002
Result type: Reports

Pathologic myopia is the seventh leading cause of blindness in the US and two percent of Americans have the disease; Canadian statistics are not available. Pathologic myopia involves elongation of the eyeball and scleral support surgery aims to control the progression of this elongation. The most commonly used technique involves placing a str...

Tags

Myopia, Sclera, Costs and Cost Analysis, Technology Assessment, Blindness, Eye, Myopia, Pathological, Eye/vision, Myopie, Sclérotique, Scleral Surgery Chirurgie, Snyder-Thompson, Borley-Snyder, Coût et analyse coût, Biomedical, Évaluation technologie biomédicale, Health technology assessment, Évaluation des technologies de la santé, HTA, ETS

Long-acting ß2-agonists for maintenance therapy of stable chronic obstructive pulmonary disease: A systematic review

Published on: September 17, 2002
Result type: Reports

Technology Name Salmeterol (Serevent®) Formoterol (Foradil®) Technology Description Salmeterol and formoterol are bronchodilators administered by inhaler. Bronchodilators are used to treat people with conditions such as chronic obstructive pulmonary disease or asthma by opening their airways, making it easier for them to breathe. There are two m...

Tags

COPD, COAD, Bronchitis, Bronchodilator Agents, Receptor, Asthma, Emphysema, COPD, Asthme, long-acting, ß2-agonists, Pulmonary, Chronic, Airflow Obstruction, Lung Disease, Emphyseme, Emphyseme Pulmonaire, Beta, 2, Foradil, Foradile, Oxis, Eolus, Atock, Neblik, Serevent, Aeromax, Arial, Salmetedur, Beglan, Betamican, Inaspir, Salmeter, Serobid, Servent, Formoterol, Bambuterol, agents bronchiques

Uterine artery embolization for the treatment of fibroids

Published on: August 20, 2002
Result type: Reports

Uterine artery embolization (UAE), or uterine fibroid embolization, is a nonsurgical treatment for uterine fibroids that preserves the uterus and offers women an alternative to surgical procedures such as hysterectomy and myomectomy. Evidence from controlled trials comparing fibroid treatments is not yet available. Case series reports indicat...

Tags

Leiomyoma, Fibroid, Fibroid Tumor, Fibroid Uterus, Fibromyoma, Myofibroma, Uterus, Tumors, Uterus Cancer, Cancer, Embolectomy, Embolotherapy, Therapeutic Embolization, Hypermenorrhea, Rupture, Treatment Effectiveness, Treatment Efficacy, Treatment, Anemia, Fibroids, Uterine, Hysterotomy, Uterine Artery Embolization, Cancer, Gynecology/obstetrics, Leiomyome, Fibroids, Uterine, Uterine Fibroma, Uterine Fibroid, Leiomyomas, Fibromas, Uterine Myoma, Uterus Myoma, Uterine Myomatosis, Uterine Fibromyomata, Benign Tumor Uterine Neoplasms, Tumeur Uterus, Cancer Uterus, Cancers, Neoplasm, Uterine Cancers, Uterus Cancers, Uterus Neoplasm Embolization, Therapeutic, Embolization Therapeutique, Embolization, Embolizations, Embolotherapies, Therapeutic Embolizations, Embolisation, Embolisations Menorrhagia, Menorragie, Heavy Bleeding, Excessive Menstrual Flow, Heavy Periods, Periods, Heavy, menorhagia Uterus, Uterus Uterine Rupture, Rupture Uterine, Ruptures, Uterine Ruptures Treatment Outcome, Evaluation Resultats Traitement, Effectiveness, Outcome, Treatment Success Treatment Failure, Echec Therapeutique, Failure, Failures, Treatment Failures, Unsuccessful Treatment, fibrome, fibromes, fibrome utérin, utérins, fibromyome, myome, myome utérin, tumeurs, leiomyome, fibromyome utérin, tumeur bénigne cancer de l’utérus, cancer utérin, utérin, cancers, néoplasme, cancers utérins, cancers de l’utérus, néoplasme de l’utérus embolectomie, embolisation, thérapie thromboembolique, embolisation thérapeutique, embolisations, thérapeutiques, traitement antithrombotique, embolisations saignement abondant, flux menstruel excessif, règles abondantes, règles, abondantes, hyperménorrhée, ménorragie utérus rupture, utérine, ruptures, utérines, ruptures utérines efficacité pratique du traitement, efficacité thérapeutique, efficacité pratique, traitement, résultat, réussite thérapeutique échec, échecs, échecs thérapeutiques, échec du traitement

Fondaparinux for post-operative venous thrombosis prophylaxis

Published on: August 20, 2002
Result type: Reports

Fondaparinux (Arixtra™) belongs to a new class of synthetic antithrombotic agents called pentasaccharides. It was recently approved in Canada for the prevention of venous thromboembolic events (VTE) in patients undergoing orthopedic surgeries of the lower limbs such as hip fracture, knee surgery and hip replacement surgery.

Tags

Fibrinolytic Agents, Factor Xa, Venous Thrombosis, Antithrombotic Agents, Enoxaparin, Enoxaparine, Pulmonary Embolism, Thrombolytic Agents, Orthopedics, Arthroplasty, Hip, Knee, Activated Factor X, Hip Fractures, Orthopedic Surgery, Total Hip Replacement, Total Knee Replacement, Thrombosis, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee, Thrombosis, Fibrinolytiques, Fondaparinux, Facteur xa, Pentasaccharides, Thrombose veineuse, Antithrombotics, Embolie pulmonaire, Orthopedie, Thrombolytics, Replacement, ArthroplastieGenou, Arixtra™, Arthroplastie Hanche, Fracture hanche, deep veinthrombosis, orthopaedic surgery, fondaparinux, pentasaccharides, agents anti-thrombotiques, anti-thrombotiques, agents thrombolytiques, thrombolytiques, Arixtra, facteur X activé, thrombose veineuse profonde, chirurgie orthopédique, arthroplastie totale de la hanche, arthroplastie totale du genou